Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Why the U.S. Doesn’t Have a Nasal Vaccine for COVID-19

Por: Time Health October 31, 2022

thumbnail

The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection. In order to put the pandemic behind us, the world will need a way to stop infections and spread of the virus. That’s where a different type of vaccine, one that works... + full article



Similar News

Afraid of needles? China using inhalable COVID-19 vaccine

WGN-TV USA Nation October 27, 2022

thumbnailPosted: Oct 27, 2022 / 08:26 AM CDT Updated: Oct 27, 2022 / 08:27 AM CDT SHARE BEIJING (AP) — The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first. The vaccine, a mist that is sucked in through the... + más

Afraid of needles? China using inhalable COVID-19 vaccine | Portland Press Herald

Afraid of needles? China using inhalable COVID-19 vaccine | Associated Press


Afraid of needles? China using inhalable COVID-19 vaccine

Associated Press USA Business October 26, 2022

thumbnailBEIJING (AP) — The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first.The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated... + más

China launches an inhalable COVID-19 vaccine in an apparent world first | Los Angeles Times

Afraid of needles? China rolling out oral COVID-19 vaccine | WPTV


China launches an inhalable COVID-19 vaccine in an apparent world first

Los Angeles Times USA Science October 26, 2022

thumbnailChina's biggest city, Shanghai, started administering an inhalable COVID-19 vaccine Wednesday in what appears to be a world first. The vaccine, a mist sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals, according... + más

China launches a COVID-19 vaccine inhaled through the mouth | 10 WBNS

China launches a COVID-19 vaccine inhaled through the mouth | WPLG Local 10


FDA authorizes Novavax Covid-19 vaccine for use as a first booster shot

CNN USA Health October 19, 2022

thumbnailCNN  —  The US Food and Drug Administration on Wednesday among adults 18 and older, at least six months after completing a primary Covid-19 vaccine series. The company announced that it has received emergency use authorization to provide a first booster dose of its vaccine... + más

FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC

US clears Novavax COVID booster dose | ABC News


Without a nasal vaccine, the U.S. edge in fighting Covid is on the line

Politico USA Health October 15, 2022

thumbnailBiden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más

Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica

Nasal COVID vaccine fails to offer desired protection in testing | The Hill


Nasal COVID vaccine fails to offer desired protection in testing

The Hill USA Health October 12, 2022

thumbnailA recent clinical trial has found less-than-promising results for a nasally administered version of AstraZeneca’s COVID-19 vaccine, with immune responses observed in only “a minority of participants.” University of Oxford researchers that not only were antibody responses... + más

Without a nasal vaccine, the U.S. edge in fighting Covid is on the line | Politico

Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica


Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab

Ars Technica USA Science October 12, 2022

thumbnailNavigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 12, 2022 5:17 pm UTC / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake... + más

Nasal COVID vaccine fails to offer desired protection in testing | The Hill

Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes



About iurex | Privacy Policy | Disclaimer |